# Expanded Access for Marizomib

> **NCT04644107** · — · NO_LONGER_AVAILABLE · sponsor: **Celgene**

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Marizomib

## Key facts

- **NCT ID:** NCT04644107
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04644107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04644107, "Expanded Access for Marizomib". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04644107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*